Biology study for head and neck adenoid cystic carcinoma
Part of Cancer, Ear, nose & throat clinical trials.
This study uses advanced tests on tissue and blood samples to understand why adenoid cystic carcinoma (a type of head and neck cancer) spreads. It aims to find new clues that may help improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with adenoid cystic carcinoma (ACC).
- Your cancer must have started in the head or neck area.
- You must have evidence that the cancer has spread to other parts of your body (metastatic disease).
- You must be willing and able to follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of a targeted cancer drug (antibody-drug conjugate) and focused radiation therapy for salivary gland cancers that have come back or spread after initial treatment. It may help patients whose cancer didn't respond to standard options.
This trial studies an experimental drug called zanzalintinib for people with adenoid cystic carcinoma that has spread or come back. The goal is to see if the drug can shrink tumors or slow the disease.
This trial tests a type of high-precision radiation (carbon ions) given to shrink head and neck adenoid cystic carcinoma that cannot be fully removed with surgery. It may help control the tumor while limiting damage to nearby normal tissues.
This trial collects tumor samples from people with head and neck squamous cell cancer to study why some cancers stop responding to standard treatments like cetuximab. The goal is to learn how resistance develops so better therapies can be found.
This Phase 1/2 study tests how well CB-103 works in people with advanced, hard-to-treat adenoid cystic carcinoma that has a specific NOTCH pathway change. The study also looks at whether combining CB-103 with either lenvatinib or abemaciclib is safe and effective for different groups of patients.
This study looks at whether surgery followed by radiation helps people with a specific type of sinus cancer called adenoid cystic carcinoma that has grown into nearby tissues. It aims to see how well this treatment works and how safe it is.
Hear when a new Adenoid Cystic Carcinoma of the Salivary Gland trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.